𝔖 Bobbio Scriptorium

✦ LIBER ✦

A phase I study of BAY 38-3441 given as a short infusion daily for five days every 3 weeks. a National Cancer Institute of Canada Clinical Trials Group Study

✍ Scribed by L. Seymour; L. Siu; G. Batist; J. Cammisano; M. Maclean; L. McIntosh; O. Petrenciuc

Book ID: 117658120
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 189 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)80750-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of T900607 given once ev

A phase I study of T900607 given once every three weeks in patients with advanced refractory cancer. A National Cancer Institute of Canada-Clinical Trials Group Study (NCIC CTG-IND 130)

✍ K.A. Gelmon; K. Belanger; C. Britton; D. Soulières; S. Janke; J. Dionne; J. Powe 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A phase I study of ZD0473 and docetaxel

A phase I study of ZD0473 and docetaxel given once every three weeks in patients with advanced refractory cancer. A National Cancer Institute of Canada-Clinical Trials Group Study (NCIC CTG-IND 131)

✍ K.A. Gelmon; D. Stewart; D. Ayers; D. Fry; L. Douglas; L.W. McIntosh; L.K. Seymo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)

✍ C Terret; S Zanetta; H Roché; J.H.M Schellens; M.N Faber; J Wanders; M Ravic; J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 218 KB

A prospective randomized EORTC intergrou

A prospective randomized EORTC intergroup Phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma: Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Marechal JM, Klotz L, Skinner E, Keane T, Claessens I, Sylvester R, European Organization for Research and Treatment of Cancer (EORTC); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Southwest Oncology Group (SWOG); Eastern Cooperative Oncology Group (ECOG). Department of Urology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium

✍ Stephen A. Boorjian; Michael L. Blute 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB